EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Binding of complement c 3b to glycoprotein gc of herpes simplex virus type 1 mapping of gc binding sites and demonstration of conserved c 3b binding in low passage clinical isolates



Binding of complement c 3b to glycoprotein gc of herpes simplex virus type 1 mapping of gc binding sites and demonstration of conserved c 3b binding in low passage clinical isolates



Journal of Virology 60(2): 470-475



The sites on glycoprotein gC of herpes simplex virus type 1 (HSV-1) which bind complement component C3b were evaluated by using (i) anti-gC monoclonal antibodies and (ii) mutants which have alterations at defined regions of the glycoprotein. Monoclonal antibodies were incubated with HSV-1-infected cells in a competitive assay to block C3b binding. Each of 12 different monoclonals, which recognize the four major antigenic sites of gC, completely inhibited C3b binding. With this approach, no one antigenic group on gC could be assigned as the C3b-binding region. Next, 21 gC mutants were evaluated for C3b binding, including 1 which failed to synthesize gC, 4 which synthesized truncated forms of the glycoprotein such that gC did not insert into the cell's membrane, and 16 which expressed gC on the cell's surface but which had mutations in various antigenic groups. Eleven strains did not bind C3b. This included the 1 strain which did not synthesize gC, the 4 strains which secreted gC without inserting the glycoprotein into the cell membrane, and 6 of 16 strains which expressed gC on the cell surface. In these six strains, the mutations were at three different antigenic sites. One hypothesis to explain these findings is that C3b binding is modified by changes in the conformation of gC which develop either after antibodies bind to gC or as a result of mutations in the gC gene. Attachment of C3b to gC was also evaluated in 31 low-passage clinical isolates of HSV-1. Binding was detected with each HSV-1 isolate, but not with nine HSV-2 isolates. Therefore, although mutants that lack C3b binding are readily selected in vitro, the C3b-binding function of gC is maintained in vivo. These results indicate that the sites on gC that bind C3b are different from those that bind monoclonal antibodies, that antibodies directed against all sites on gC block C3b binding, and that C3b binding is a conserved function of gC in vivo.

(PDF emailed within 1 workday: $29.90)

Accession: 004826270

Download citation: RISBibTeXText



Related references

Binding of complement component C3b to glycoprotein gC of herpes simplex virus type 1: mapping of gC-binding sites and demonstration of conserved C3b binding in low-passage clinical isolates. Journal of Virology 60(2): 470-475, 1986

Differential mapping of Fcc-binding and monoclonal antibody-reactive epitopes on gE, the Fcc-binding glycoprotein of herpes simplex virus type 1. Journal of Immunology 149: 15-27, 1992

Differential mapping of Fc gamma-binding and monoclonal antibody-reactive epitopes on gE, the Fc gamma-binding glycoprotein of herpes simplex virus type 1. Journal of Immunology 149(7): 2415-2427, 1992

Glycoprotein c gc of herpes simplex virus type 2 hsv 2 is a complement binding protein. Federation Proceedings 46(3): 773, 1987

Binding of complement c 3b to glycoprotein c is modulated by sialic acid on herpes simplex virus type 1 infected cells. Journal of Virology 55(3): 857-861, 1985

Binding of complement component C3b to glycoprotein C is modulated by sialic acid on herpes simplex virus type 1-infected cells. Journal of Virology 55(3): 857-861, 1985

The ICP4 binding sites in the herpes simplex virus type 1 glycoprotein D (gD) promoter are not essential for efficient gD transcription during virus infection. Journal of Virology 66(2): 623-631, 1992

Relationship between TATA-binding protein and herpes simplex virus type 1 ICP4 DNA-binding sites in complex formation and repression of transcription. Journal of Virology 69(9): 5568-5575, 1995

Characterisation of the nucleotide and DNA coeffector binding sites of the herpes simplex virus type 1 (HSV-1) encoded helicase-primase complex and UL9 origin binding protein. Biochemical and Biophysical Research Communications 199(3): 1333-1340, 1994

The conserved dna binding domains encoded by the herpes simplex virus type 1 icp4 pseudorabies virus ie180 and varicella zoster virus orf62 genes recognize similar sites in the corresponding promoters. Journal of Virology 65(3): 1149-1159, 1991

The central segment of herpes simplex virus type 1 glycoprotein C (gC) is not involved in C3b binding: demonstration by using monoclonal antibodies and recombinant gC expressed in Escherichia coli. Journal of General Virology 70: 1571-1578, 1989

DNA binding activity of the herpes simplex virus type 1 origin binding protein, UL9, can be modulated by sequences in the N terminus: correlation between transdominance and DNA binding. Journal of Virology 80(9): 4491-4500, 2006

Analysis of complement component c3b binding regions of herpes simplex virus glycoprotein c. Journal of Cellular Biochemistry Supplement (16 PART C): 128, 1992

Similarities and differences in the Fc-binding glycoprotein (gE) of herpes simplex virus types 1 and 2 and tentative mapping of the viral gene for this glycoprotein. Journal of Virology 41(1): 137-144, 1982